tradingkey.logo
tradingkey.logo
Search

Regenxbio Inc

RGNX
Add to Watchlist
8.530USD
-0.030-0.35%
Close 09-11 16:00ET
460.94MMarket Cap
LossP/E TTM

RGNX Financials

See Regenxbio Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
460.94M
Dividend TTM
0.00
P/E TTM
-1.52
EPS TTM
-5.60
Revenue
170.44M
Net Profit
-227.10M
ROE
-196.43%
ROA
-69.65%

Regenxbio Inc Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
0.43/0.06
Revenue / Forecast
108.02M/117.13M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
131.23%0.43
-1550.32%-1.72
-28.98%-1.30
-2.15%-1.20
-31.46%-1.38
108.55%0.12
29.61%-1.01
16.67%-1.17
36.74%-1.05
9.76%-1.38
-3.25%-1.43
---1.41
---1.66
---1.53
---1.38
---5.11
----
----
----
----
Revenue
405.73%108.02M
-92.82%6.39M
43.00%30.34M
22.88%29.73M
-4.20%21.36M
469.79%89.01M
-4.50%21.21M
-16.31%24.20M
11.60%22.30M
-18.37%15.62M
-29.13%22.21M
9.06%28.91M
-38.81%19.98M
-13.86%19.14M
-92.14%31.34M
-13.85%26.51M
48.17%32.65M
17.66%22.22M
1758.96%398.65M
-68.89%30.77M
Net Profit
132.04%22.71M
-1580.37%-90.05M
-31.19%-67.15M
-3.93%-61.94M
-33.75%-70.87M
109.61%6.08M
18.61%-51.19M
3.67%-59.60M
26.47%-52.99M
5.02%-63.33M
-4.93%-62.89M
18.04%-61.87M
-5.69%-72.06M
13.10%-66.68M
-120.38%-59.94M
-29.24%-75.48M
-18.29%-68.18M
-53.02%-76.72M
735.85%294.02M
-764.37%-58.41M
Net Margin
106.34%21.02%
-20711.74%-1408.59%
8.26%-221.34%
15.42%-208.32%
-39.61%-331.81%
101.69%6.83%
14.78%-241.28%
-15.11%-246.30%
34.11%-237.67%
-16.36%-405.39%
-48.07%-283.12%
---213.97%
---360.72%
---348.40%
---191.21%
---270.81%
----
----
----
----
Gross Margin
30.98%99.04%
-176.16%-73.22%
14.59%80.46%
65.44%80.75%
43.89%75.61%
32.45%96.14%
42.12%70.22%
-14.61%48.81%
-0.04%52.55%
-7.55%72.58%
-16.57%49.41%
--57.16%
--52.57%
--78.51%
--59.22%
--48.68%
----
----
----
----
Debt to assets ratio
--46.95%
--51.87%
--41.28%
--36.49%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
405.73%108.02M
-92.82%6.39M
43.00%30.34M
22.88%29.73M
-4.20%21.36M
469.79%89.01M
-4.50%21.21M
-16.31%24.20M
11.60%22.30M
-18.37%15.62M
-29.13%22.21M
9.06%28.91M
-38.81%19.98M
-13.86%19.14M
-92.14%31.34M
-13.85%26.51M
48.17%32.65M
17.66%22.22M
1758.96%398.65M
-68.89%30.77M
Operating profit
146.25%29.26M
-787.41%-83.36M
-12.20%-57.64M
15.57%-52.41M
-12.92%-63.28M
119.64%12.13M
19.62%-51.37M
4.44%-62.08M
23.35%-56.04M
6.64%-61.76M
-10.61%-63.90M
8.56%-64.96M
-16.91%-73.11M
7.51%-66.16M
-118.42%-57.77M
-23.88%-71.05M
-19.74%-62.53M
-62.41%-71.53M
684.51%313.60M
-511.07%-57.35M
Net Profit
132.04%22.71M
-1580.37%-90.05M
-31.19%-67.15M
-3.93%-61.94M
-33.75%-70.87M
109.61%6.08M
18.61%-51.19M
3.67%-59.60M
26.47%-52.99M
5.02%-63.33M
-4.93%-62.89M
18.04%-61.87M
-5.69%-72.06M
13.10%-66.68M
-120.38%-59.94M
-29.24%-75.48M
-18.29%-68.18M
-53.02%-76.72M
735.85%294.02M
-764.37%-58.41M
Current assets
-36.81%236.16M
-40.46%186.52M
1.18%281.28M
5.93%331.97M
7.81%373.75M
-20.78%313.24M
-17.01%278.00M
-14.33%313.40M
-8.48%346.68M
1.60%395.42M
-19.47%334.97M
-16.21%365.84M
-18.61%378.81M
-12.91%389.20M
-19.82%415.98M
6.45%436.64M
6.41%465.42M
-10.38%446.88M
-2.33%518.83M
6.00%410.16M
Total current liabilities
-30.88%82.62M
-33.37%71.11M
14.44%118.09M
21.26%124.57M
21.64%119.54M
-3.13%106.73M
-20.79%103.19M
-19.33%102.72M
-16.64%98.27M
-1.92%110.18M
-0.12%130.27M
3.07%127.35M
2.91%117.89M
-6.34%112.33M
-0.03%130.43M
15.71%123.55M
25.12%114.56M
42.85%119.94M
60.19%130.47M
67.84%106.77M
Total assets
-33.46%386.62M
-30.36%341.89M
-2.78%453.03M
1.17%525.20M
2.05%581.03M
-21.98%490.93M
-18.81%465.99M
-18.09%519.11M
-16.57%569.38M
-15.86%629.22M
-31.12%573.97M
-28.29%633.79M
-28.42%682.46M
-27.07%747.83M
-25.19%833.27M
10.42%883.79M
13.99%953.44M
16.59%1.03B
57.29%1.11B
47.90%800.39M
Total liabilities
-14.29%314.85M
48.02%320.81M
69.77%350.30M
67.09%363.75M
66.14%367.35M
-9.15%216.73M
-21.31%206.34M
-19.58%217.70M
-20.06%221.11M
-15.61%238.55M
-17.30%262.23M
-15.40%270.69M
-14.34%276.60M
-15.79%282.69M
-9.31%317.07M
-5.61%319.97M
-1.89%322.93M
3.31%335.70M
5.81%349.61M
170.07%338.98M
Total equity
-66.41%71.77M
-92.31%21.08M
-60.43%102.73M
-46.44%161.45M
-38.65%213.68M
-29.81%274.20M
-16.71%259.65M
-16.99%301.42M
-14.19%348.27M
-16.01%390.67M
-39.61%311.74M
-35.60%363.10M
-35.63%405.86M
-32.56%465.14M
-32.46%516.20M
22.19%563.82M
24.30%630.52M
24.38%689.67M
102.33%764.30M
11.01%461.41M
Net operating income
-26.14%-62.24M
-326.55%-76.19M
-65.35%-52.29M
-38.01%-55.96M
-8.45%-49.34M
160.64%33.63M
22.41%-31.62M
17.93%-40.55M
3.86%-45.50M
31.47%-55.45M
-3.53%-40.76M
2.08%-49.41M
23.36%-47.32M
-44.73%-80.92M
-112.07%-39.37M
-18.71%-50.46M
-71.18%-61.75M
-26.93%-55.91M
726.59%326.24M
-16.57%-42.50M
Net investment
146.94%65.92M
57.76%70.59M
-6.79%37.54M
-15.86%42.29M
-52301.49%-140.44M
239.40%44.74M
18.54%40.27M
30.01%50.26M
-100.49%-268.00K
-79.11%13.18M
27.24%33.97M
-27.12%38.66M
5208.05%55.22M
169.65%63.09M
112.34%26.70M
229.44%53.04M
-113.86%-1.08M
57.70%-90.59M
-1970.00%-216.36M
-52.64%16.10M
Net financing
-87.38%17.57M
-135.40%-13.64M
-23.82%-9.58M
34.76%-7.08M
1574.13%139.23M
-104.80%-5.79M
35.30%-7.74M
-125.95%-10.86M
-3.09%-9.45M
1435.90%120.72M
-34.10%-11.96M
11.30%-4.80M
-19.47%-9.16M
-32.24%-9.04M
-216.69%-8.92M
-137.28%-5.42M
-24.96%-7.67M
-103.23%-6.83M
-96.06%7.64M
-256.37%-2.28M

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What is the total revenue of Regenxbio Inc?

According to Regenxbio Inc's FY2025 earnings report, its total revenue reached 170.44M, with a year-on-year change of 83.33M.

What are the current assets of Regenxbio Inc?

According to Regenxbio Inc's FY2025 earnings report, its current assets were 281.28M, with a year-on-year change of 1.18.

What are the total assets of Regenxbio Inc?

According to Regenxbio Inc's FY2025 earnings report, its total assets of Regenxbio Inc were 453.03M, with a year-on-year change of -2.78.

What are the total liabilities of Regenxbio Inc?

According to Regenxbio Inc's FY2025 earnings report, its total liabilities of Regenxbio Inc were 350.30M, with a year-on-year change of 69.77.

What is the total equity of Regenxbio Inc?

According to Regenxbio Inc's FY2025 earnings report, its total equity of Regenxbio Inc was 102.73M, with a year-on-year change of -60.43.

What is the net operating income of Regenxbio Inc?

According to Regenxbio Inc's FY2025 earnings report, its net operating income of Regenxbio Inc was -161.10M, with a year-on-year change of 30.06.

What is the net investment of Regenxbio Inc?

According to Regenxbio Inc's FY2025 earnings report, its net investment of Regenxbio Inc was -15.87M, with a year-on-year change of -115.34.

What is the net financing of Regenxbio Inc?

According to Regenxbio Inc's FY2025 earnings report, its net financing of Regenxbio Inc was 116.77M, with a year-on-year change of 25.99.

What is the Earnings Per Share (EPS) of Regenxbio Inc?

According to Regenxbio Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.76, with a year-on-year change of 18.05.

What is the net income of Regenxbio Inc?

According to Regenxbio Inc's FY2025 earnings report, its net income was -193.88M, with a year-on-year change of 14.63.

What is the net margin of Regenxbio Inc?

According to Regenxbio Inc's FY2025 earnings report, its net profit margin was -113.75, with a year-on-year change of 58.26.

What is the gross margin of Regenxbio Inc?

According to Regenxbio Inc's FY2025 earnings report, its gross margin was 88.09, with a year-on-year change of 47.51.

What is the debt-to-asset ratio of Regenxbio Inc?

According to Regenxbio Inc's FY2025 earnings report, its debt-to-asset ratio was 41.28, with a year-on-year change of 222.29.

What is the Return on Equity (ROE) of Regenxbio Inc?

According to Regenxbio Inc's FY2025 earnings report, its Return on Equity (ROE) was -107.00, with a year-on-year change of -34.61.

What is the Return on Assets (ROA) of Regenxbio Inc?

According to Regenxbio Inc's FY2025 earnings report, its Return on Assets (ROA) was -42.19, with a year-on-year change of 3.40.

What is the operating profit of Regenxbio Inc?

According to Regenxbio Inc's FY2025 earnings report, its operating profit was -161.10M, with a year-on-year change of 30.06.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.